Muhl, Lars http://orcid.org/0000-0003-0952-0507
Genové, Guillem http://orcid.org/0000-0002-8558-3107
Leptidis, Stefanos http://orcid.org/0000-0003-0172-4193
Liu, Jianping http://orcid.org/0000-0002-7336-3895
He, Liqun
Mocci, Giuseppe
Sun, Ying
Gustafsson, Sonja
Buyandelger, Byambajav
Chivukula, Indira V.
Segerstolpe, Åsa
Raschperger, Elisabeth
Hansson, Emil M.
Björkegren, Johan L. M. http://orcid.org/0000-0003-1945-7425
Peng, Xiao-Rong
Vanlandewijck, Michael
Lendahl, Urban
Betsholtz, Christer http://orcid.org/0000-0002-8494-971X
Article History
Received: 28 January 2020
Accepted: 10 July 2020
First Online: 7 August 2020
Change Date: 3 September 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: X.-R.P. is an employee of AstraZeneca, C.B. is a consultant for AstraZeneca. The remaining authors declare no competing interests.